Korean J Urol.  2007 Oct;48(10):1022-1026. 10.4111/kju.2007.48.10.1022.

Metabolic Risk Factors and Treatment Effects of Extracorporeal Shock Wave Lithotripsy in the Medullary Sponge Kidney with Nephrocalcinosis

Affiliations
  • 1Department of Urology, College of Medicine, Chung-Ang University, Seoul, Korea. moon2580@cau.ac.kr

Abstract

PURPOSE: The medullary sponge kidney(MSK) is a congenital anomaly of the renal medulla characterized by fusiform and cystic dilatation of the collecting tubules confined to the renal pyramids. The aim of this study is to evaluate the metabolic risk factors and effect of extracorporeal shock wave lithotripsy(ESWL) and complications in an MSK with nephrocalcinosis.
MATERIALS AND METHODS
We compared stone metabolic studies between 45 patients with MSK and 279 non-MSK patients. We evaluated the effect of ESWL for MSK. Group A patients received ESWL and follow-up within 3 months and Group B patients had a period of cessation for more than 6 months. The frequency of complications between group A and group B patients was compared.
RESULTS
There were no statistically differences between the MSK group and non-MSK group of patients in the stone metabolic studies. Among the 45 patients with MSK, 26(58%) had one or several of the following metabolic disorders: hypocitraturia(36.7%), hypercalciuria(18.3%), hyperoxaluria(16.3%), hyperuricosuria(16.3%), low urine volume(12.4%). The percentage of patients that experienced more than 75% of a reduction of stone burden on plain films was 48.8%, 25?75% of the reduction was 35.6%, and less than 25% of the reduction was 15.6%. The most common complication was renal colic(17.7%). Renal colic and stone re-growth was shown to have a more significant association with group B patients as compared to group A patients.
CONCLUSIONS
ESWL reduced the stone burden more than 75% in 48.8% of MSK patients with nephrocalcinosis, and prevented flank pain, and obstructive uropathy. Therefore, we plan to develop treatments that are more effective.

Keyword

Medullary sponge kidney; Extracorporeal shockwave lithotripsy; Risk factors

MeSH Terms

Dilatation
Flank Pain
Follow-Up Studies
Humans
Lithotripsy*
Medullary Sponge Kidney*
Nephrocalcinosis*
Porifera
Renal Colic
Risk Factors*
Shock*

Reference

1. Glassberg KI. Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Renal dysgenesis and cystic disease of the kidney. Campbell's urology. 2002. 8th ed. Philadelphia: Saunders;1925–1985.
2. Harrison AR, Rose GA. Medullary sponge kidney. Urol Res. 1979. 7:197–207.
3. Holmes SA, Eardley I, Corry DA, Nockler I, Whitfield HN. The use of extracorporeal shock wave lithotripsy for medullary spongy kidney. Br J Urol. 1992. 70:352–354.
4. Choi DG, Kim BJ, Rim JS. Clinical experience with extracorporeal shock wave lithotripsy for nephrocalcinosis in medullary spongy kidney: a report of 7 cases. Korean J Urol. 1994. 35:397–401.
5. Nakada SY, Erturk E, Monaghan J, Cockett AT. Role of extracorporeal shock-wave lithotripsy in treatment of urolithiasis in patients with medullary sponge kidney. Urology. 1993. 41:331–333.
6. O'Neill M, Breslau NA, Pak CY. Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney. JAMA. 1981. 245:1233–1236.
7. Higashihara E, Nutahara K, Niijima T. Renal hypercalciuria and metabolic acidosis associated with medullary sponge kidney: effect of alkali therapy. Urol Res. 1988. 16:95–100.
8. Ginalski JM, Portmann L, Jaeger P. Dose medullary sponge kidney cause nephrolithiasis? AJR Am J Roentgenol. 1990. 155:299–302.
9. Yagisawa T, Kobayashi C, Hayashi T, Yoshida A, Toma H. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis. 2001. 37:1140–1143.
10. Moon YT, Oh MM, Choi IG, Kim KD, Kim SC. Experience with extracorporeal shock wave lithotripsy (ESWL): a report of 400 cases. Korean J Urol. 1988. 29:29–37.
11. Jung SY, Park YH. Analysis of urinary calculi in voided urine after ESWL. Korean J Urol. 1990. 31:839–844.
12. Kuiper JJ. Gardner KD, editor. Medullary sponge kidney. Cystic diseases of the kidney. 1976. New York: John Wiley & Sons;151–153.
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr